Roche Diagnostics International AG
- Home
- Companies
- Roche Diagnostics International AG
- Products
- Elecsys - Model Total -Tau CSF - Robust ...
Most popular related searches
immunoassay intended
clinical validation
clinical chemistry
cerebrospinal fluid
immunoassay
Alzheimer
Alzheimer disease
immunoassay diagnostic
amyloid beta
cerebrospinal
Elecsys® tTau assay is part of the Elecsys® AD portfolio, along with Elecsys® β-Amyloid(1-42) CSF II (AB42 2) and Elecsys® Phospho-Tau (181P) CSF (pTau) immunoassays.1
Elecsys® AD CSF assays can detect amyloid positivity, enhancing diagnostic accuracy and physician confidence.2,3
Elecsys® AD CSF assays enable timely intervention by identifying patients with MCI at risk of progression to AD.1,3
The Power of Elecsys® in Alzheimer’s disease
Robust, clinically validated results to help ensure patients get the care they deserve